| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Enanta Pharma (NASDAQ:ENTA) is preparing to release its quarterly earnings on Monday, 2025-11-17. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Enanta Pharma to report an earnings per share (EPS) of $-1.06.
The announcement from Enanta Pharma is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
In the previous earnings release, the company beat EPS by $0.18, leading to a 5.7% increase in the share price the following trading session.
Here's a look at Enanta Pharma's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.03 | -1.46 | -1.35 | -1.41 |
| EPS Actual | -0.85 | -1.06 | -1.05 | -1.36 |
| Price Change % | 6.00 | -6.00 | 14.00 | -5.00 |
Shares of Enanta Pharma were trading at $11.72 as of November 13. Over the last 52-week period, shares are up 22.47%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Enanta Pharma visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ENTA
